Hepa-Merz Granules

L-ornithine L-aspartate 3,00 g

Expand All
Collapse All

Active ingredient

Active substance:
• L-ornithine L-aspartate 3,00 g
Additional substances: 
• Anhydrous citric acid, lemon flavour, orange flavour, sodium saccharin, sodium cyclamate, orange-yellow S (Е 110), povidone К 25, laevulose.


  • Acute and chronic liver diseases, accompanied with hyperammoniemia (hepatitis, cirrhosis, hepatic steatosis, toxic hepatic lesions).
  • Treatment of concomitant and secondary symptoms under violations of detoxification function of liver.
  • Hepatic encephalopathy (delitescent and clinically apparent), especially within a complex treatment of incipient disturbance of consciousness (pre-coma) or coma.

Dosage and Administration

3–6 g per os x 3 times daily.


Apparent renal dysfunction (with creatinine level exceeding 3 mg/100 ml of blood plasma).

Side effects

  • Cutaneous reactions are rarely observed.
  • In specific cases: nausea, vomiting.

Drug Interaction

As no compatibility studies have been performed, the medicinal product must not be mixed with other medicinal products.

Pregnancy and Lactation

No data available.

Warning and Precaution

Preparation is prescribed with prudence to patients, involved in potentially dangerous activities, demanding increased reaction and quickness of psychomotor action.

Package and Storage

  • Package: Packs of 6 sachets.
  • Storage: Store at room temperature, out of the reach of children.

Mother Company

Manufactured by Marcyrl , Under licence from MERZ